{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:11:11Z","timestamp":1781716271855,"version":"3.54.5"},"reference-count":89,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["AP19576783"],"award-info":[{"award-number":["AP19576783"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiologia"],"abstract":"<jats:p>Systemic sclerosis (SSc) is an autoimmune connective tissue disorder characterized by vascular abnormalities, immune dysfunction, and progressive fibrosis. One of the most common manifestations of SSc is interstitial lung disease (ILD), known by a progressive course leading to significant morbidity and mortality. Aim: to investigate autoantibodies, cytokines, and genetic markers in SSc-ILD through a systematic review and analysis of a Kazakh cohort of SSc-ILD patients. Methods: A PubMed search over the past 10 years was performed with \u201cSSc-ILD\u201d, \u201cautoantibodies\u201d, \u201ccytokines\u201d, and \u201cgenes\u201d. Thirty patients with SSc were assessed for lung involvement, EScSG score, and modified Rodnan skin score. IL-6 was measured by ELISA, antinuclear factor on HEp-2 cells by indirect immunofluorescence, and specific autoantibodies by immunoblotting. Genetic analysis was performed using a 120-gene AmpliSeq panel on the Ion Proton platform. Results: The literature review identified 361 articles, 26 addressed autoantibodies, 20 genetic variants, and 12 cytokine profiles. Elevated levels of IL-6, TGF-\u03b2, IL-33, and TNF-\u03b1 were linked to SSc. Based on the results of the systemic review, we created a preliminary immunogenic panel for SSc-ILD with following analysis in Kazakh patients with SSc (n = 30). Fourteen of them (46.7%) demonstrated signs of ILD and\/or lung hypertension, with frequent detection of antibodies such as Scl-70, U1-snRNP, SS-A, and genetic variants in SAMD9L, REL, IRAK1, LY96, IL6R, ITGA2B, AIRE, TREX1, and CD40 genes. Conclusions: Current research confirmed the presence of the broad range of autoantibodies and variations in IRAK1, TNFAIP3, SAMD9L, REL, IRAK1, LY96, IL6R, ITGA2B, AIRE, TREX1, CD40 genes in of Kazakhstani cohort of SSc-ILD patients.<\/jats:p>","DOI":"10.3390\/epidemiologia6030041","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T10:13:51Z","timestamp":1754475231000},"page":"41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic Sclerosis with Interstitial Lung Disease: Identification of Novel Immunogenetic Markers and Ethnic Specificity in Kazakh Patients"],"prefix":"10.3390","volume":"6","author":[{"given":"Lina","family":"Zaripova","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, JSC National Scientific Medical Center, Astana Medical University, 42 Abylai Khan Ave., Astana 010009, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abay","family":"Baigenzhin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JSC National Scientific Medical Center, Astana Medical University, 42 Abylai Khan Ave., Astana 010009, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5114-5803","authenticated-orcid":false,"given":"Zhanar","family":"Zarkumova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JSC National Scientific Medical Center, Astana Medical University, 42 Abylai Khan Ave., Astana 010009, Kazakhstan"},{"name":"School of Residency, Department of Internal Medicine No. 2, NCJSC Astana Medical University, 49\/A Beibitshilik St., Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Zhabakova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JSC National Scientific Medical Center, Astana Medical University, 42 Abylai Khan Ave., Astana 010009, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyona","family":"Boltanova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JSC National Scientific Medical Center, Astana Medical University, 42 Abylai Khan Ave., Astana 010009, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-1055","authenticated-orcid":false,"given":"Maxim","family":"Solomadin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JSC National Scientific Medical Center, Astana Medical University, 42 Abylai Khan Ave., Astana 010009, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Pak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, JSC National Scientific Medical Center, Astana Medical University, 42 Abylai Khan Ave., Astana 010009, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12016-022-08946-w","article-title":"Systemic sclerosis-specific antibodies: Novel and classical biomarkers","volume":"64","author":"Cavazzana","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.23950\/jcmk\/15493","article-title":"Respiratory support for patients with chronic respiratory failure: The necessity of a long-term homecare ventilation program","volume":"21","author":"Baigenzhin","year":"2024","journal-title":"J. Clin. Med. Kaz."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cozzani, E., Muracchioli, A., Murdaca, G., Beccalli, M., Caprioli, S., Zentilin, P., Ameri, P., Grosso, M., Russo, R., and Carmisciano, L. (2021). Correlation between skin and affected organs in 52 sclerodermic patients followed in a diseases management team: Development of a risk prediction model of organ-specific complications. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.588753"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/art.23379","article-title":"Fibroblast-specific perturbation of transforming growth factor beta signaling provides insight into potential pathogenic mechanisms of scleroderma-associated lung fibrosis: Exaggerated response to alveolar epithelial injury in a novel mouse model","volume":"58","author":"Hoyles","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semarthrit.2016.02.004","article-title":"Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study","volume":"46","author":"Richardson","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","article-title":"Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: Clinical, radiologic, histopathologic, and treatment evidence","volume":"40","author":"Christmann","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/rheumatology\/kead023","article-title":"Anti-acid therapy in SSc-associated interstitial lung disease: Long-term outcomes from the German Network for Systemic Sclerosis","volume":"62","author":"Kreuter","year":"2023","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1164\/ajrccm.179.12.1167a","article-title":"Gastroesophageal reflux and lung disease in systemic sclerosis","volume":"179","author":"Belloli","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","article-title":"Esophageal involvement and pulmonary manifestations in systemic sclerosis","volume":"45","author":"Marie","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1513\/AnnalsATS.201606-426FR","article-title":"Treatment of systemic sclerosis-related interstitial lung disease: A review of existing and emerging therapies","volume":"13","author":"Volkmann","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/07853890.2023.2179659","article-title":"Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease","volume":"55","author":"Jang","year":"2023","journal-title":"Ann. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1378\/chest.08-0053","article-title":"Clinically significant interstitial lung disease in limited scleroderma: Histopathology, clinical features, and survival","volume":"134","author":"Fischer","year":"2008","journal-title":"Chest"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1148\/radiol.2322031223","article-title":"CT features of lung disease in patients with systemic sclerosis: Comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia","volume":"232","author":"Desai","year":"2004","journal-title":"Radiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: Systematic review and meta-analysis","volume":"44","author":"Royo","year":"2014","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"103297","DOI":"10.1016\/j.jaut.2024.103297","article-title":"Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD)","volume":"148","author":"Westra","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.resinv.2024.03.006","article-title":"Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review","volume":"62","author":"Enomoto","year":"2024","journal-title":"Respir. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","article-title":"Interstitial lung disease in progressive systemic sclerosis: High-resolution CT versus radiography","volume":"176","author":"Schurawitzki","year":"1990","journal-title":"Radiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41431-018-0104-8","article-title":"Genetic predictors of systemic sclerosis-associated interstitial lung disease: A review of recent literature","volume":"26","author":"Stock","year":"2018","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejim.2023.07.010","article-title":"Prevalence of anti-synthetase antibodies among systemic sclerosis patients","volume":"117","author":"Garra","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Geroldinger-Simi\u0107, M., Bayati, S., Pohjanen, E., Sepp, N., Nilsson, P., and Pin, E. (2023). Autoantibodies against PIP4K2B and AKT3 are associated with skin and lung fibrosis in patients with systemic sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065629"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.42491","article-title":"A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis-Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study","volume":"75","author":"Jee","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e002076","DOI":"10.1136\/bmjresp-2023-002076","article-title":"Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: A systematic review and meta-analysis","volume":"10","author":"Nayebirad","year":"2023","journal-title":"BMJ Open Respir. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1093\/rheumatology\/keab433","article-title":"The scleromyositis phenotype. Lessons from a multicentre international cohort of anti-PM\/Scl-positive patients","volume":"60","year":"2021","journal-title":"Rheumatology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cerro-Chiang, G., Ayres, M., Rivas, A., Romero, T., Parker, S.J., Mastali, M., Elashoff, D., Chen, P., Van Eyk, J.E., and Wolters, P.J. (2023). Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-35840-y"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4236\/ojra.2015.53013","article-title":"Anti-RNA Polymerase III antibodies in systemic sclerosis","volume":"5","author":"Kelly","year":"2015","journal-title":"Open J. Rheumatol. Autoimmun. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"103220","DOI":"10.1016\/j.jaut.2024.103220","article-title":"Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis","volume":"146","author":"Chevalier","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/acr2.11398","article-title":"The Effect of Anti-Scl-70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis","volume":"4","author":"Jandali","year":"2022","journal-title":"ACR Open Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bjd.17886","article-title":"Anti-C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis","volume":"181","author":"Liaskos","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17116\/terarkh201587342-47","article-title":"Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux","volume":"87","author":"Sosnovskaya","year":"2015","journal-title":"Ter. Arkh."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e8980","DOI":"10.1097\/MD.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Fritzler, M.J., Bentow, C., Beretta, L., Palterer, B., Perurena-Prieto, J., Sanz-Mart\u00ednez, M.T., Guillen-Del-Castillo, A., Mar\u00edn, A., Fonollosa-Pla, V., and Callejas-Moraga, E. (2023). Anti-U11\/U12 antibodies as a rare but important biomarker in patients with systemic sclerosis: A narrative review. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071257"},{"key":"ref_38","first-page":"274","article-title":"Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis","volume":"36","author":"Becker","year":"2019","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"Sestini","year":"2013","journal-title":"J. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.30647","article-title":"Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3","volume":"64","author":"Brissett","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11703","DOI":"10.1038\/ncomms11703","article-title":"Tenascin-C drives persistence of organ fibrosis","volume":"7","author":"Bhattacharyya","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/ard.2006.067967","article-title":"Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?","volume":"67","author":"Carulli","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis\u2014A longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Al-Adwi, Y., Atzeni, I.M., Doornbos-van der Meer, B., van der Leij, M.J., Varkevisser, R.D.M., Kroesen, B.J., Stel, A., Timens, W., Gan, C.T., and van Goor, H. (2023). High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: Evidence from observational, clinical, transcriptomic and in vitro studies. EBioMedicine, 98.","DOI":"10.1016\/j.ebiom.2023.104883"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2018.08.003","article-title":"Guidelines for biomarkers in autoimmune rheumatic diseases\u2014Evidence based analysis","volume":"18","author":"Giacomelli","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-017-9993-5","article-title":"Blood biomarkers in idiopathic pulmonary fibrosis","volume":"195","author":"Guiot","year":"2017","journal-title":"Lung"},{"key":"ref_47","first-page":"246","article-title":"Transforming growth factor-\u03b2-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblasts","volume":"7","author":"Ikeda","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.2147\/JIR.S379815","article-title":"Biomarkers in the pathogenesis, diagnosis, and treatment of systemic sclerosis","volume":"16","author":"Muruganandam","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/ard.2010.137349","article-title":"An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis","volume":"70","author":"Codullo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cei.13238","article-title":"The immunopathogenesis of fibrosis in systemic sclerosis","volume":"195","author":"Brown","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Renaud, L., da Silveira, W.A., Takamura, N., Hardiman, G., and Feghali-Bostwick, C. (2020). Prominence of IL6, IGF, TLR, and bioenergetics pathway perturbation in lung tissues of scleroderma patients with pulmonary fibrosis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00383"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/1346-8138.14580","article-title":"Rapid alteration of serum interleukin-6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis-associated interstitial lung disease","volume":"45","author":"Numajiri","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.1302470","article-title":"Blockade of IL-6 trans signaling attenuates pulmonary fibrosis","volume":"193","author":"Le","year":"2014","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13075-016-1127-6","article-title":"Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families","volume":"18","author":"Kuo","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Boleto, G., Campochiaro, C., Distler, O., Balanescu, A., Launay, D., Bergmann, C., Air\u00f2, P., Oksel, F., Gheorghiu, A.M., and Anic, B. (2025). Interstitial lung disease in anti-U1RNP systemic sclerosis patients: A European Scleroderma Trials and Research analysis. J. Scleroderma Relat. Disord., in press.","DOI":"10.1177\/23971983251324827"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/acr.24411","article-title":"Trends in systemic sclerosis mortality over forty-eight years, 1968\u20132015: A US population-based study","volume":"73","author":"Yen","year":"2021","journal-title":"Arthritis Care Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/art.1780390814","article-title":"Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y","article-title":"Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody","volume":"42","author":"Kuwana","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/annrheumdis-2011-200901","article-title":"IRF5 polymorphism predicts prognosis in patients with systemic sclerosis","volume":"71","author":"Sharif","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_60","first-page":"20","article-title":"The influence of STAT4 rs7574865 (G\/T) polymorphism on the risk of clinical and immunological phenotypes of systemic sclerosis in a Russian patient population: Results of a pilot study","volume":"89","author":"Krylov","year":"2017","journal-title":"Ter. Arkh."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00296-017-3722-5","article-title":"The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms","volume":"37","author":"Zhao","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_62","first-page":"471","article-title":"Association Study of CD226 and CD247 Genes Single Nucleotide Polymorphisms in Iranian Patients with Systemic Sclerosis","volume":"16","author":"Abbasi","year":"2017","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ijd.12839","article-title":"Polymorphisms in STAT4 and IRF5 Increase the Risk of Systemic Sclerosis: A Meta-Analysis","volume":"55","author":"Xu","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2018-214865","article-title":"Single-Cell Analysis Reveals Fibroblast Heterogeneity and Myofibroblasts in Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"78","author":"Valenzi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Xu, Z., and Chen, C. (2022). The Downregulation of PTGS2 Mediated by ncRNAs is Tightly Correlated with Systemic Sclerosis-Interstitial Lung Disease. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.795034"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3109\/08820139.2013.789910","article-title":"The CTLA-4 and MCP-1 Polymorphisms and Susceptibility to Systemic Sclerosis: A Meta-Analysis","volume":"42","author":"Song","year":"2013","journal-title":"Immunol. Investig."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"108133","DOI":"10.1016\/j.isci.2023.108133","article-title":"An Interleukin 6 Responsive Plasma Cell Signature Is Associated with Disease Progression in Systemic Sclerosis Interstitial Lung Disease","volume":"26","author":"Jia","year":"2023","journal-title":"iScience"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13075-016-1054-6","article-title":"miR-155 in the Progression of Lung Fibrosis in Systemic Sclerosis","volume":"18","author":"Christmann","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-Function SAMD9L Mutations Cause a Syndrome of Cytopenia, Immunodeficiency, MDS, and Neurological Symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1947601911421925","article-title":"The c-Rel Transcription Factor in Development and Disease","volume":"2","author":"Gilmore","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pde.15411","article-title":"A diffuse, pustular eruption in a neonate: Recognizing SAMD9L-associated autoinflammatory disease (SAAD)","volume":"41","author":"Miller","year":"2024","journal-title":"Pediatr Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2018.10.002","article-title":"Impact of Alterations in X-Linked IRAK1 Gene and miR-146a on Susceptibility and Clinical Manifestations in Patients with Systemic Sclerosis","volume":"204","author":"Vreca","year":"2018","journal-title":"Immunol. Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/ijmm.2022.5210","article-title":"Mechanisms and application strategies of miRNA-146a regulating inflammation and fibrosis at molecular and cellular levels","volume":"51","author":"Liao","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Yang, H., Li, J., Jiang, L., Jiang, X., Zhou, X., and Xu, N. (2018). The rs878081 Polymorphism of AIRE Gene Increases the Risk of Rheumatoid Arthritis in a Chinese Han Population: A Case-Control Study. Braz. J. Med. Biol. Res., 51.","DOI":"10.1590\/1414-431x20187944"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar4141","article-title":"Association of the AIRE Gene with Susceptibility to Rheumatoid Arthritis in a European Population: A Case Control Study","volume":"15","author":"Teruel","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1073\/pnas.1423804112","article-title":"Exonuclease TREX1 Degrades Double-Stranded DNA to Prevent Spontaneous Lupus-Like Inflammatory Disease","volume":"112","author":"Grieves","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/0961203315583543","article-title":"Associations between the Functional CD40 rs4810485 G\/T Polymorphism and Susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Meta-Analysis","volume":"24","author":"Lee","year":"2015","journal-title":"Lupus"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00296-017-3797-z","article-title":"Endothelin-1, \u03b1-Klotho, 25(OH) Vit D Levels and Severity of Disease in Scleroderma Patients","volume":"37","author":"Hajialilo","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_79","first-page":"831","article-title":"Increased Levels of Endothelin-1 and Differential Endothelin Type A and B Receptor Expression in Scleroderma-Associated Fibrotic Lung Disease","volume":"151","author":"Abraham","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/rheumatology\/kez230","article-title":"Biomarkers in Systemic Sclerosis-Associated Interstitial Lung Disease: Review of the Literature","volume":"58","author":"Bonhomme","year":"2019","journal-title":"Rheumatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"548","DOI":"10.46497\/ArchRheumatol.2021.8625","article-title":"Screening and Identification of Potential Biomarkers and Therapeutic Targets for Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"36","author":"Huang","year":"2021","journal-title":"Arch. Rheumatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/annrheumdis-2021-220493","article-title":"Integrative Analysis of Lung Molecular Signatures Reveals Key Drivers of Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"81","author":"Jung","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1513\/pats.201203-023AW","article-title":"The Impact of TGF-\u03b2 on Lung Fibrosis: From Targeting to Biomarkers","volume":"9","author":"Fernandez","year":"2012","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/157339710793205611","article-title":"Role of Growth Factors in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis","volume":"6","author":"Castro","year":"2010","journal-title":"Curr. Rheumatol. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased Serum Levels and Tissue Expression of Matrix Metalloproteinase-12 in Patients with Systemic Sclerosis: Correlation with Severity of Skin and Pulmonary Fibrosis and Vascular Damage","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_86","first-page":"135","article-title":"Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis","volume":"9","author":"Tochimoto","year":"2016","journal-title":"Clin. Med. Insights Circ. Respir. Pulm. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"van Caam, A., Vonk, M., van den Hoogen, F., van Lent, P., and van der Kraan, P. (2018). Unraveling SSc Pathophysiology; The Myofibroblast. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02452"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/2397198320903867","article-title":"Pathogenesis of Systemic Sclerosis Associated Interstitial Lung Disease","volume":"5","author":"Nihtyanova","year":"2020","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/03009742.2024.2335718","article-title":"Bicaudal D2 autoantibodies are highly specific for systemic sclerosis","volume":"53","author":"Iversen","year":"2024","journal-title":"Scand. J. Rheumatol."}],"container-title":["Epidemiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-3986\/6\/3\/41\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:24:20Z","timestamp":1760034260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-3986\/6\/3\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":89,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["epidemiologia6030041"],"URL":"https:\/\/doi.org\/10.3390\/epidemiologia6030041","relation":{},"ISSN":["2673-3986"],"issn-type":[{"value":"2673-3986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}